Global Ankylosing Spondylitis Market 2015-2019: Subtype Of Spondylarthropathy Analyzed

1
Global Ankylosing Spondylitis Market 2015-2019
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published January 2014
• Single User PDF US 3000
• Corporate User PDF US 4000

2
Global Ankylosing Spondylitis Market 2015-2019

• Ankylosing spondylitis is a subtype of
  spondylarthropathy. The primary symptoms of the
  disease are inflammatory spinal pain with
  subsequent limitation of spine mobility and chest
  expansion. Ankylosing spondylitis can be
  diagnosed using clinical signs, radiological
  signs (sacroiliitis) and the presence of HLA-B27
  antigen. According to the NIH and NIAMS,
  ankylosing spondylitis is a type of arthritis,
  which affects the joints in the vertebral column
  severely. It is a progressive inflammatory
  disease that typically becomes evident during
  early to mid-adulthood, as per NORD. It can also
  lead to the loss of spinal mobility for the
  affected individuals. The cause of the disease is
  not known, however, the HLA-B27 gene plays a
  major role. Ankylosing spondylitis is hereditary
  in nature.
• Analysts forecast the Global Ankylosing
  Spondylitis market to grow at a CAGR of 5.05
  percent over the period 2014-2019.
• Covered in this Report
• This report covers the present scenario and the
  growth prospects of the Global Ankylosing
  Spondylitis market for the period 2015-2019. To
  calculate the market size, the report considers
  revenue generated from the sales of various drugs
  used in the treatment of ankylosing spondylitis.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Global Ankylosing Spondylitis Market 2015-2019

• The market is segmented based on the mechanism of
  action of the drugs used to treat ankylosing
  spondylitis as illustrated below
• TNF Inhibitors
• COX Inhibitors
• Others
• Single User License US 3000 Inquire for
  Discount _at_ http//www.reportsnreports.com/contacts
  /Discount.aspx?name323157.
• On the type of molecule used for the treatment of
  ankylosing spondylitis, as illustrated below
• Biologics
• Small Molecules 
•  
• On the basis of route of administration adopted
  for the treatment of ankylosing spondylitis, the
  Global Ankylosing Spondylitis market is segmented
  as follows
• Oral
• Parenteral

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Global Ankylosing Spondylitis Market 2015-2019

• In addition, the market is also bifurcated on the
  basis of dosage forms of the drugs used in the
  treatment of the disease
• Solid
• Liquid
• The report also presents the vendor landscape and
  a corresponding detailed analysis of the top five
  vendors in the market. The vendor landscape
  section includes a market share analysis of the
  major vendors along with the competitive
  performances of their product portfolios. In
  addition, it discusses the major drivers that
  influence the growth of the market and also
  outlines the challenges faced by the vendors and
  the market at large, as well as the key trends
  that are emerging in the market. Also, the
  late-stage pipeline molecules developed for the
  treatment of Ankylosing Spondylitis have been
  discussed.
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name323157.
• Global Ankylosing Spondylitis Market 2015-2019,
  has been prepared based on an in-depth market
  analysis with inputs from industry experts. The
  report covers the Americas, the APAC region and
  the EMEA it also covers the Global Ankylosing
  Spondylitis market landscape and its growth
  prospects in the coming years. The report also
  includes a discussion on the key vendors
  operating in this market.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Global Ankylosing Spondylitis Market 2015-2019

• Key Regions
• Americas, APAC, EMEA
• Key Vendors
• Abbvie, Amgen, Janssen Pharmaceuticals, Merck
  Co., Pfizer
• Other Prominent Vendors
• Boehringer Ingelheim, Bristol-Myers Squibb,
  Celgene, Celltrion, Eisai, F. Hoffmann-La Roche,
  Merck Sharp Dohme, Novartis Otsuka
  Pharmaceutical, Regeneron Pharmaceuticals,
  Sanofi, Shanghai Pharmaceuticals, UCB
• Market Driver
• Presence of Unmet Need
• Market Challenge
• Threat from Patent Expiry

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Global Ankylosing Spondylitis Market 2015-2019

• Market Trend
• Market Dominance by Biologics
• Inquiry Before Buying _at_ http//www.reportsnreports
  .com/contacts/InquiryBeforeBuy.aspx?name323157.
• Key Questions Answered in this Report
• What will the market size be in 2019 and what
  will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth? 
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by the key vendors?
• What are the strengths and weaknesses of the key
  vendors?
• List of Exhibits
• Exhibit 1 Market Research MethodologyExhibit 2
  Executive Summary of Global Ankylosing
  Spondylitis Market 2014-2019Exhibit 3 Snapshot
  of Ankylosing SpondylitisExhibit 4 Diagnosis of
  Ankylosing SpondylitisExhibit 5 Treatment and
  Management of Ankylosing Spondylitis

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
7
Global Ankylosing Spondylitis Market 2015-2019

• Exhibit 6 Snapshot of the Economic Burden of
  Ankylosing SpondylitisExhibit 7 Snapshot of the
  Global Ankylosing Spondylitis MarketExhibit 8
  Global Ankylosing Spondylitis Market 2014-2019
  (US million)Exhibit 9 Drivers and Challenges
  of Global Ankylosing Spondylitis MarketExhibit
  10 Global Ankylosing Spondylitis Market
  Segmentation by Mechanism of ActionExhibit 11
  Global Ankylosing Spondylitis Market Segmentation
  by Mechanism of Action 2014Exhibit 12 Global
  Ankylosing Spondylitis Market Segmentation by
  Type of MoleculeExhibit 13 Global Ankylosing
  Spondylitis Market Segmentation by Type of
  Molecule 2014Exhibit 14 Global Ankylosing
  Spondylitis Market Segmentation by Route of
  AdministrationExhibit 15 Global Ankylosing
  Spondylitis Market Segmentation by Route of
  Administration 2014Exhibit 16 Global Ankylosing
  Spondylitis Market Segmentation by Dosage
  FormsExhibit 17 Global Ankylosing Spondylitis
  Market Segmentation by Dosage Forms 2014Exhibit
  18 Global Ankylosing Spondylitis Market by
  Geographical Segmentation 2014Exhibit 19 Buying
  Criteria of the Global Ankylosing Spondylitis
  MarketExhibit 20 Drivers and their Impact on
  the Key Customer Category of the Global
  Ankylosing Spondylitis MarketExhibit 21 Drivers
  and Their Geography-wise Impact on the Global
  Ankylosing Spondylitis MarketExhibit 22 YoY
  Sales Comparison of Top Drugs used for Ankylosing
  Spondylitis 2010-2013 (US million)Exhibit 23
  Revenue Share of the Top Drugs used for
  Ankylosing Spondylitis 2010-2013Exhibit 24
  Abbvie Product Portfolio for Ankylosing
  Spondylitis

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
8
Global Ankylosing Spondylitis Market 2015-2019

• Exhibit 25 YoY Global Sales of Humira 2008-2013
  (US million)Exhibit 26 Janssen Product
  Portfolio for Ankylosing SpondylitisExhibit 27
  YoY Sales of Remicade 2005-2013 (US
  million)Exhibit 28 YoY Sales of Simponi
  2010-2013 (US million)Exhibit 29 Amgen
  Product Portfolio for Ankylosing Spondylitis 
• Exhibit 30 YoY Sales of Enbrel (In US and
  Canada) 2005-2013 (US million)Exhibit 31 YoY
  Sales of Enbrel In US 2005-2013 (US
  million)Exhibit 32 YoY Sales of Enbrel In
  Canada 2005-2013 (US million)Exhibit 33
  Region-wise Sales Comparison of Enbrel 2005-2013
  (US million)Exhibit 34 Pfizer Product
  Portfolio for Ankylosing SpondylitisExhibit 35
  YoY Sales of Enbrel (Outside US and Canada)
  2009-2013 (US million)Exhibit 36 YoY Sales of
  Enbrel (Outside US and Canada) 2008-2013 (US
  million)Exhibit 37 Merck Product Portfolio for
  Ankylosing SpondylitisExhibit 38 YoY Sales of
  Remicade 2005-2013 (US million)Exhibit 39 YoY
  Sales of Simponi 2010-2013 (US million)Exhibit
  40 AbbVie Inc. Product Segmentation by Revenue
  2013Exhibit 41 AbbVie Inc. Product
  Segmentation by Revenue 2012 and 2013 (US
  million)Exhibit 42 AbbVie Inc. Sales by
  Geography 2013Exhibit 43 Amgen Business
  Segmentation by Revenue 2013

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
9
Global Ankylosing Spondylitis Market 2015-2019

• Exhibit 44 Amgen Product Portfolio by Revenue
  2013Exhibit 45 Amgen Business Segmentation by
  Revenue 2012 and 2013 (US billion)Exhibit 46
  Amgen Geographical Segmentation by Revenue
  2013Exhibit 47 Merck Co. Inc. Business
  Segmentation by Revenue 2013Exhibit 48 Merck
  Co. Inc. Business Segmentation by Revenue 2012
  and 2013 (US billion)Exhibit 49 Merck Co.
  Inc. Sales by Geography 2013Exhibit 50 Pfizer
  Business Segmentation by Revenue 2013Exhibit 51
  Pfizer Business Segmentation by Revenue 2012 and
  2013Exhibit 52 Pfizer Geographical
  Segmentation by Revenue 2013
• Explore Report on Pharmaceuticals Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Global
  Ankylosing Spondylitis Market 2015-2019 report
  OR for any other market research and intelligence
  needs you may have for your business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.